Teleperformance USA recognized for demonstrating a commitment to caring for their people and their communities PARIS–(BUSINESS…
Autor: Press Room
35 years of experience in the field of communications specialized in various business areas, such as administration, marketing, writing, public relations and more.
All In On Green: Many Tonnes of Waste Flow Into the Sea From the World’s Rivers: a Danish Robot Minimises This Pollution
VIBORG, Denmark–(BUSINESS WIRE)–At least 70 cities in Europe can now prevent huge amounts of waste from…
Clovis Oncology Files for Chapter 11 Protection and Enters into Agreement to Sell FAP-2286
Receives Commitment for up to $75 Million in Debtor-in-Possession Financing BOULDER, Colo.–(BUSINESS WIRE)–$CLVS–Clovis Oncology, Inc. (NASDAQ:CLVS)…
Archaea Energy Inc. (LFG) Investigation Alert: Robbins LLP is Investigating the Acquisition of Archaea Energy Inc. by BP p.l.c (BP) on Behalf of Shareholders
SAN DIEGO–(BUSINESS WIRE)–$BP #ArchaeaEnergyInc–Shareholder rights law firm Robbins LLP informs investors it is investigating the acquisition…
AlloVir Announces Positive Final Results in Phase 2 Posoleucel Multi-Virus Prevention Study In Oral Presentation at the 64th ASH Annual Meeting and Exposition
23 of 26 (88%) patients remained free of clinically significant infections caused by any of six…
Interim Data From Phase III Study Presented at ASH 2022 Show Hemlibra (emicizumab-kxwh) Achieved Meaningful Bleed Control in Infants From Birth
– The HAVEN 7 study was designed to further confirm the benefit of preventative treatment (prophylaxis)…
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Progyny, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES–(BUSINESS WIRE)–$PGNY #PGNY—The Schall Law Firm, a national shareholder rights litigation firm, announces that it…
Incyte Announces Data from Two LIMBER Studies Evaluating Combination Treatments in Patients with Myelofibrosis (MF) Presented at ASH 2022
– Phase 2 data demonstrate that the addition of parsaclisib to ruxolitinib (Jakafi®) resulted in spleen…
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims on Behalf of Investors in FTX Tokens
LOS ANGELES–(BUSINESS WIRE)–$FTT #FTT—The Schall Law Firm, a national shareholder rights litigation firm, announces that it…
Pfizer Presents Updated Favorable Elranatamab Data from Pivotal Phase 2 MagnetisMM-3 Trial
Data showed high objective response rate of 61% in RRMM patients with no prior BCMA-targeted treatment,…